Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discoveryAnders Lundin, Marcello Maresca|Nature Communications|2020Cited by 99
ObLiGaRe doxycycline Inducible (ODIn) Cas9 system driving pre-clinical drug discovery, from design to cancer treatmentAnders Lundin, Marcello Maresca|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 3